Skip to content

Latest

New9mControversial ‘Downstate’ Delays First Broadway Preview Due To IllnessDeadline
New10mThe ‘ungodly spending’ behind the creator economyNews Feed
New10mAnthony Mackie Is Seeking Revenge In ’12 12 12′ TrailerDeadline
New29mLondon Stock Exchange owner in talks to buy credit specialist OctusNews Feed
32mApple refreshes its Homepod mini with a new chip and $149 price tagTechCrunch
AdYour message here: reach every reader in the headline ticker
33mApple’s new smart home line-up includes a smart lock, thermostat and video doorbellsTechCrunch
33mHillary Clinton, Kara Swisher to Launch Political Podcast ‘High Stakes’The Hollywood Reporter
35mWhy we need a proper conversation about deathNews Feed
40m‘Ek Pukur Bhalobasa’: Kolkata Pandal Revives Bengal's Love For PondsNDTV
40mPM Modi Calls India 'Mother Of Democracy', Says 'People Debate Openly On All Issues'NDTV
42mRusty or something more? South Africa's concern after Australia lossBBC News
42mThe final Disrupt Stage lineup: Three days of conversations you won’t hear anywhere outside of TechCrunch Disrupt 2026TechCrunch
43mIs Zelensky right to say data centre strikes have taken down Russian bots?BBC News
44mRahul Gandhi Targets PM Modi, HM Shah: 'Won't Let Them Get Away With Destroying Constitution'NDTV

Business News Feed10h

Biotech start-ups turn to reverse mergers to fast-track listings

Life sciences companies take advantage of the leftovers of a pandemic-era IPO frenzy to fast-track listings

Read Original Article

#Public health #Mergers & acquisitions